AG
ROIV icon

Algert Global’s Roivant Sciences ROIV Stock Holding History

Algert Global’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9M Buy
845,118
+17,664
+2% +$522K 0.35% 27
2026
Q1 		$22.9M Buy
827,454
+120,900
+17% +$3.11M 0.34% 40
2025
Q4 		$15.3M Buy
+706,554
New +$13.9M 0.24% 96
2024
Q3 		– Sell
-46,331
Closed -$490K – 1525
2024
Q2 		$490K Sell
46,331
-102,329
-69% -$1.12M 0.02% 924
2024
Q1 		$1.57M Sell
148,660
-45,618
-23% -$492K 0.06% 490
2023
Q4 		$2.18M Buy
194,278
+81,828
+73% +$797K 0.09% 384
2023
Q3 		$1.31M Buy
+112,450
New +$1.27M 0.06% 502

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Algert Global's ROIV Position: Q2 2026 in Review

Algert Global increased its Roivant Sciences (ROIV) stake by 2.1% in Q2 2026, buying an estimated $522K and bringing the position to 845,118 shares worth $29.9M. The position accounts for 0.35% of the portfolio, ranked #27.

Algert Global first reported a position in ROIV in Q3 2023 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Algert Global held 845,118 shares of Roivant Sciences worth $29.9M as of Q2 2026.
  • Algert Global bought 17,664 Roivant Sciences shares in Q2 2026, an estimated $522K.
  • Roivant Sciences made up 0.35% of Algert Global's portfolio in Q2 2026, its #27 holding.
  • Algert Global first reported a position in Roivant Sciences in Q3 2023 and has held it in 7 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.